TY - JOUR
T1 - COVID-19 and diabetes in 2020
T2 - a systematic review
AU - Javid, Farideh A.
AU - Waheed, Fadi Abdul
AU - Zainab, Nisa
AU - Khan, Hamza
AU - Amin, Ibrahim
AU - Bham, Ammar
AU - Ghoghawala, Mohammed
AU - Sheraz, Aneem
AU - Haloub, Radi
N1 - Funding Information:
We thank Professor Gillian Hawksworth for proofreading the paper.
Publisher Copyright:
© 2023, The Author(s).
PY - 2023/3/9
Y1 - 2023/3/9
N2 - Attempts were made to review the literature on diabetic patients who experience complications when they contract COVID-19, and to determine whether ethnicity and other risk factors play an important role in the development of symptoms and their severity, as well as responding to medications. A literature search was performed using five keywords, namely COVID-19, diabetes, ethnicity, medications, and risk factors between January 2019 and December 2020 using electronic databases such as PubMed, Science Direct, Google Scholar, Springer Link, and Scopus. Forty studies were included. The review indicated that diabetes was a significant risk factor for poorer outcomes and increased mortality associated with COVID-19. There were several risk factors for diabetic patients that increased their likelihood of poorer outcomes associated with COVID-19. These included black and Asian ethnicity, male sex with high BMI. In conclusion, patients with diabetes of black or Asian origin with high BMI, male sex, and older age had an increased risk of poorer outcomes associated with COVID-19. This highlights the importance of considering the history of the patient in prioritising care and treatment.
AB - Attempts were made to review the literature on diabetic patients who experience complications when they contract COVID-19, and to determine whether ethnicity and other risk factors play an important role in the development of symptoms and their severity, as well as responding to medications. A literature search was performed using five keywords, namely COVID-19, diabetes, ethnicity, medications, and risk factors between January 2019 and December 2020 using electronic databases such as PubMed, Science Direct, Google Scholar, Springer Link, and Scopus. Forty studies were included. The review indicated that diabetes was a significant risk factor for poorer outcomes and increased mortality associated with COVID-19. There were several risk factors for diabetic patients that increased their likelihood of poorer outcomes associated with COVID-19. These included black and Asian ethnicity, male sex with high BMI. In conclusion, patients with diabetes of black or Asian origin with high BMI, male sex, and older age had an increased risk of poorer outcomes associated with COVID-19. This highlights the importance of considering the history of the patient in prioritising care and treatment.
KW - COVID-19
KW - Diabetes
KW - Ethnicity
KW - Risk factors
UR - http://www.scopus.com/inward/record.url?scp=85149944684&partnerID=8YFLogxK
U2 - 10.1186/s40545-023-00546-z
DO - 10.1186/s40545-023-00546-z
M3 - Review article
AN - SCOPUS:85149944684
VL - 16
JO - Journal of Pharmaceutical Policy and Practice
JF - Journal of Pharmaceutical Policy and Practice
SN - 2052-3211
IS - 1
M1 - 42
ER -